Benitec Biopharma Limited advised that Dr. Craig Lewis has agreed to serve as Chief Medical Adviser (part-time) on the company's non-small cell lung cancer (NSCLC) program. Dr. Lewis is medical oncologist at Prince of Wales Hospital.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.41 USD | -0.84% | -0.63% | +191.33% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+191.33% | 79.98M | |
+64.92% | 62.86B | |
-1.85% | 41.38B | |
+45.32% | 40.38B | |
-8.93% | 27.64B | |
+13.05% | 26.46B | |
-21.96% | 18.9B | |
+4.21% | 12.67B | |
+25.74% | 12.27B | |
+27.42% | 12.07B |
- Stock Market
- Equities
- BNTC Stock
- News Benitec Biopharma Inc.
- Benitec Biopharma Limited Appoints Craig Lewis as Chief Medical Adviser